Skip to main content
. 2021 Nov 9;9:760800. doi: 10.3389/fcell.2021.760800

TABLE 1.

The characteristics of include cohorts.

Characteristics TCGA (n = 508)
CGGA (n = 444)
Samples (n = 29)
N % N % N %
Age (y)
 ≤40 251 49.41 229 51.58 6 20.69
 >40 257 50.59 214 48.20 23 79.31
 NA 0 0.00 1 0.23 0 0.00
Gender
 Female 282 55.51 193 43.47 6 20.69
 Male 226 44.49 251 56.53 23 79.31
Grade
 II 246 48.43 189 42.57 12 41.38
 III 262 51.57 255 57.43 17 58.62
Histological type
 A 128 25.20 271 61.04 9 31.03
 OA 188 37.01 30 6.76 0 0.00
 O 192 37.80 142 31.98 3 10.34
 NA 0 0.00 1 0.23 17 58.62
IDH1 status
 Wildtype 34 6.69 96 21.62 6 20.69
 Mutation 91 17.91 307 69.14 18 62.07
 NA 383 75.39 41 9.23 5 17.24
Radiation therapy
 Yes 142 27.95 315 70.95 0 0.00
 No 119 23.43 102 22.97 0 0.00
 NA 247 48.62 27 6.08 29 100.00
Chemotherapy
 Yes 277 54.53 285 64.19 0 0.00
 No 229 45.08 132 29.73 0 0.00
 NA 2 0.39 27 6.08 29 100.00

A, astrocytoma; IDH1, isocitrate dehydrogenase 1; NA, not available; O, oligodendroglioma; OA, oligoastrocytoma.